WeVote
Log In

Bill

Bill

HB 729

AN ACT relating to pharmaceutical drug safety and declaring an emergency.

2026 Regular Session Introduced by Robert Duvall and 2 co-sponsors

The bill establishes Kentucky-wide safety standards for pharmaceutical drugs and declares an emergency to enable rapid rulemaking and enforcement.

to Licensing, Occupations, & Administrative Regulations (H)
#administrativeregulationsandproceedings #boardsandcommissions #civilactions #correctionsimpact #crimesandpunishments #drugsandmedicines #effectivedates #emergency #healthandmedicalservices #healthcareprofessionals #nurses #pharmacists #physicians #safety #shorttitlesandpopularnames
0
WeVote Research Nonpartisan
Bill Summary · HB 729

Overview

HB 729, introduced in the Kentucky House in the 2026 Session (Session: 2026RS), is titled “AN ACT relating to pharmaceutical drug safety and declaring an emergency.” The bill has been referred to the Licensing, Occupations, & Administrative Regulations Committee and originated in the House, with earlier referral to the Committee on Committees.

Purpose and Intent

  • The bill aims to address pharmaceutical drug safety within Kentucky.
  • It includes provisions that the sponsors designate as an emergency measure, indicating it is intended to take effect promptly to respond to drug safety concerns.

Key Provisions and Changes (as described by the bill’s title and status)

Note: The full text of specific sections is not provided here, but the bill’s title and committee referrals suggest the following areas are likely addressed:

  • Regulation and oversight of pharmaceutical drugs: Provisions may establish or enhance state regulatory authority over the safety, distribution, prescription, or labeling of pharmaceuticals within Kentucky.
  • Emergency declaration and effective date: The designation of “declaring an emergency” typically enables quicker implementation of safety measures, possible temporary rules, inspections, or enforcement actions.
  • Standards and compliance requirements: The bill may set new criteria for manufacturers, distributors, pharmacies, or prescribers to meet safety standards, reporting obligations, or recordkeeping.
  • Enforcement and penalties: Provisions could include penalties or corrective actions for noncompliance with the new safety requirements.
  • Coordination with agencies: Likely coordination with relevant state agencies (e.g., health, licensing boards, public safety) to implement drug-safety measures.

Because the text is not provided, the exact provisions, thresholds, fees, or penalties cannot be cited here.

Who/What Would Be Affected

  • Pharmaceutical manufacturers and distributors operating in Kentucky: Subject to new or strengthened safety standards and reporting requirements.
  • Licensed healthcare practitioners and pharmacies: Potentially affected by changes in prescribing, dispensing, labeling, or compliance processes.
  • State regulatory and licensing agencies: Granted or clarified authority to enforce drug safety measures and administer emergency provisions.
  • General public in Kentucky: Indirectly affected through enhanced drug safety measures, potential protections against unsafe medications, and expedited regulatory actions during declared emergencies.

Procedural and Timeline Aspects

  • Introduction and referral: Introduced on February 25, 2026; referred to the Committee on Committees, then to the Licensing, Occupations, & Administrative Regulations Committee on March 4, 2026.
  • Emergency provision: The bill explicitly declares an emergency, which typically affects the effective date and may allow for temporary or expedited rulemaking and enforcement actions upon enactment.
  • Next steps: The bill would need approval by the Kentucky House (and later the Senate) and, if enacted, would include a specific effective date, which could be immediate or date-stamped depending on the emergency declaration.

Notes and Considerations

  • The exact text, including definitions, specific authorities granted, enforcement mechanisms, and financial implications (if any fees or funding are involved), is not included in the provided summary. For a complete understanding, the full bill language and accompanying fiscal notes would be necessary.
  • As an emergency measure, stakeholders should monitor for rapid implementation steps, potential temporary rules, and any transition guidance issued by relevant Kentucky agencies.

If you’d like, I can update this with line-by-line details once the bill’s full text and fiscal impact statement are available.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.